Capillaroscopic skin ulcers risk index (CSURI) calculated with different videocapillaroscopy devices: How its predictive values change

Clinical and Experimental Rheumatology

Volumn 31, Issue SUPPL.76, 2013, Pages

  Sebastiani, Marco ^a   Manfredi, Andreina ^a   Lo Monaco, Andrea ^b   Praino, Emanuela ^c   Riccieri, Valeria ^d   Grattagliano, Vito ^c   Bortoluzzi, Alessandra ^b   Stefanantoni, Katia ^d   D'Amico, Roberto ^a   Giuggioli, Dilia ^a   Ferri, Clodoveo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Digital ulcers; Systemic sclerosis; Videocapillaroscopy

Indexed keywords

ADULT; ANALYTICAL EQUIPMENT; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CAPILLAROSCOPIC SKIN ULCERS RISK INDEX; CAPILLAROSCOPY; COMPARATIVE STUDY; FEMALE; FINGER ULCER; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTIVE VALIDITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS; VIDEOCAPILLAROSCOPY DEVICE; AGED; ANGIOSCOPY; CLINICAL TRIAL; EQUIPMENT; FINGER; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; RISK FACTOR; SKIN; SKIN ULCER; STANDARD; VALIDATION STUDY; VASCULARIZATION;

ADULT; AGED; FEMALE; FINGERS; HUMANS; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; SKIN; SKIN ULCER;

EID: 84883808717     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. FERRI C, VALENTINI G, COZZI F et al.: Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002; 81: 139-53.
2. HACHULLA E, LAUNAY D: Diagnosis and Classification of Systemic Sclerosis. Clin Rev Allergy Immunol 2011; 40: 78-83.
3. KHANNA D, KOWAL-BIELECKA O, KHANNA PP et al.: Quality indicator set for systemic sclerosis. Clin Exp Rheumatol 2011; 29 (Suppl. 65): S33-9.
4. STEEN V, DENTON CP, POPE JE, MATUCCICERINIC M: Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology (Oxford) 2009; 48 (Suppl. 3): iii19-24.
5. ZELENIETZ C, POPE J: Differences in disability as measured by the Health Assessment Questionnaire between patients with and without digital ulcers in systemic sclerosis: a post hoc analysis of pooled data from two randomised controlled trials in digital ulcers using bosentan. Ann Rheum Dis 2010; 69: 2055-6.
6. RICCIERI V, STEFANANTONI K, VASILE M et al.: Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Clin Exp Rheumatol 2011; 29 (Suppl. 65): S46-52.
7. PAULING JD, SHIPLEY JA, HARRIS ND, McHUGH NJ: Use of infrared thermography as an endpoint in therapeutic trials of Raynaud's phenomenon and systemic sclerosis. Clin Exp Rheumatol 2012; 30 (Suppl. 71): S103-15.
8. SEBASTIANI M, MANFREDI A, COLACI M et al.: Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 2009; 61: 688-94.
9. SEBASTIANI M, MANFREDI A, VUKATANA G et al.: Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis 2012; 71: 67-70.
10. WILDT M, WUTGGE DM, SCHEJA A: Assessment of capillary density in systemic sclerosis with three capillaroscopic methods. Clin Exp Rheumatol 2012; 30 (Suppl. 71): S50- 54.
11. Subcommitte for scleroderma criteria of the American Rheumatism Ass ociation Diagnostica and Therapeutic Criteria Committe: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
12. KORN JH, MAYES M, MATUCCI-CERINIC M et al.: Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004; 50: 3985-93.
13. BATTICCIOTTO A, ATZENI F, FOGLIA S, ANTIVALLE M, SERAFIN A, SARZI-PUTTINI P: Feet nailfold capillaroscopy is not useful to detect the typical scleroderma pattern. Clin Exp Rheumatol 2012; 30 (Suppl. 71): S116-7.
14. CUTOLO M, PIZZORNI C, TUCCIO M et al.: Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004; 43: 719-26.